M&A
-
Inside P&C’s news team runs you through the key M&A deals from the past week. -
The deal will result in a pre-tax net realized gain of $86mn in the second quarter.
-
Inside P&C’s morning summary of the key stories to get you up to speed fast.
-
Organic growth accelerated to 11.1% in Q1 while the top 25% of performers posted “stratospheric” organic growth of over 17.5%.
-
Morgan Stanley and Golman Sachs exercised in full their right to buy 945,000 shares in the company.
-
Talanx said the transaction will make the company the third-largest P&C insurer in Latin America.
-
Inside P&C’s news team runs you through the key M&A deals from the past week.
-
Inside P&C’s morning summary of the key stories to get you up to speed fast.
-
Sources said the (re)insurer held an equity interest of approximately 20% in the Miami-based MGA.
-
The recent deal is accretive at 18% and will allow RenRe to take further advantage of the hard market.
-
The group exited an off-strategy business at an attractive valuation – now it must give a clearer indication of where it is going.
-
The transaction will coincide with a CEO succession as Karl Wall hands the reins to M&A head Tom Nichols.
